Associated Papers
Clinical Characteristics of CARD14-Associated Papulosquamous Eruption and Evaluation of Therapeutic Efficacy of Secukinumab.
Zhao X et al.
Journal of Inflammation Research, 2025
A novel variant with a severe phenotype in a patient with CARD14-associated papulosquamous eruption successfully treated with ixekizumab.
Ouyang X et al.
Clinical and Experimental Dermatology, 2024
Case report: Successful treatment with biologics in a pediatric patient with a severe inflammatory skin disease and novel CARD14 mutation.
Niedźwiedź M et al.
Frontiers in Medicine, 2024
Successful treatment with ustekinumab in CARD14-associated papulosquamous eruption in a Brazilian child.
Kiszewski AE et al.
Dermatologic Therapy, 2022
Select a paper to view details